Efficacy and safety of transarterial chemoembolization combined with sintilimab and bevacizumab in hepatocellular carcinoma

ObjectiveTransarterial chemoembolization (TACE) is standard of care for patients with unresectable hepatocellular carcinoma (uHCC) that is amenable to embolization; however, its long-term prognosis is limited. Recently, TACE with systemic therapies showed meaningful improvement in clinical outcomes....

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yi Wu, Miaoshen Yu, Tonggang Zhou, Yunfei Tian, Yusheng Song
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2026-01-01
Colecção:	Frontiers in Oncology
Assuntos:	bevacizumab biosimilar efficacy hepatocellular carcinoma safety sintilimab transarterial chemoembolization
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1739249/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!